nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An erudite encounter with: Sir David Goldberg
|
|
|
2017 |
51 |
1 |
p. 103-104 |
artikel |
2 |
ANZJP: The first fifty years MCMLXVII–MMXVII
|
Malhi, Gin S |
|
2017 |
51 |
1 |
p. 9-14 |
artikel |
3 |
A rise in Australian suicide? A reflection on the 2016 cause of death statistics
|
Milner, Allison |
|
2017 |
51 |
1 |
p. 99-100 |
artikel |
4 |
Changes in metabolic parameters in patients with severe mental illness over a 10-year period: A retrospective cohort study
|
Heald, Adrian H |
|
2017 |
51 |
1 |
p. 75-82 |
artikel |
5 |
Examining the association between social cognition and functioning in individuals at ultra-high risk for psychosis
|
Cotter, Jack |
|
2017 |
51 |
1 |
p. 83-92 |
artikel |
6 |
Fifty-Fifty
|
Malhi, Gin S |
|
2017 |
51 |
1 |
p. 5-6 |
artikel |
7 |
Good guidelines but should the emphasis be on implementation?
|
Hatcher, Simon |
|
2017 |
51 |
1 |
p. 15-17 |
artikel |
8 |
Hippocampal neurochemical markers in bipolar disorder patients following the first-manic episode: A prospective 12-month proton magnetic resonance spectroscopy study
|
Silveira, Leonardo E |
|
2017 |
51 |
1 |
p. 65-74 |
artikel |
9 |
How long will we sleep on obstructive sleep apnoea in schizophrenia?
|
Myles, Hannah |
|
2017 |
51 |
1 |
p. 95-96 |
artikel |
10 |
Inflammatory cytokines in major depressive disorder: A case–control study
|
Cassano, Paolo |
|
2017 |
51 |
1 |
p. 23-31 |
artikel |
11 |
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
|
Cusin, Cristina |
|
2017 |
51 |
1 |
p. 55-64 |
artikel |
12 |
Neuroleptic malignant syndrome (or malignant extrapyramidal autonomic syndrome): Time to revisit diagnostic criteria and terminology?
|
Menon, Vikas |
|
2017 |
51 |
1 |
p. 102 |
artikel |
13 |
Occipital bending in schizophrenia
|
Maller, Jerome J |
|
2017 |
51 |
1 |
p. 32-41 |
artikel |
14 |
Paediatric bipolar disorder: What are the dangers of treating a hypothetical disorder as a real disease?
|
Allison, Stephen |
|
2017 |
51 |
1 |
p. 98 |
artikel |
15 |
Pharmacogenomics in psychiatry – Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration
|
Kulkarni, Jayashri |
|
2017 |
51 |
1 |
p. 93-94 |
artikel |
16 |
Retrospective: Pursuing melancholia – The Australian contribution
|
Parker, Gordon |
|
2017 |
51 |
1 |
p. 7-8 |
artikel |
17 |
SAD schmad: Is seasonal affective disorder a valid construct?
|
Murray, Greg |
|
2017 |
51 |
1 |
p. 18-19 |
artikel |
18 |
Seizure, sclerosis or space-occupying lesions?
|
Drane, Andrew |
|
2017 |
51 |
1 |
p. 101 |
artikel |
19 |
Surface-based brain morphometry and diffusion tensor imaging in schizoaffective disorder
|
Landin-Romero, Ramón |
|
2017 |
51 |
1 |
p. 42-54 |
artikel |
20 |
The importance of the physical health needs of people with psychotic disorders
|
Suetani, Shuichi |
|
2017 |
51 |
1 |
p. 94-95 |
artikel |
21 |
Treatment of a female patient with persistent genital arousal and Parkinson’s disease with paliperidone
|
Fountoulakis, Konstantinos N |
|
2017 |
51 |
1 |
p. 98-99 |
artikel |
22 |
Trichotillomania and other ‘manias’: A lesson in inconsistency, selective concern about stigma and political correctness
|
Starcevic, Vladan |
|
2017 |
51 |
1 |
p. 97 |
artikel |
23 |
Why do stimulants not work in typical depression?
|
Hegerl, Ulrich |
|
2017 |
51 |
1 |
p. 20-22 |
artikel |